With Fermion, start the journey of your innovative API.

Virtual Booth

Contact Supplier

Suanfarma CDMO offers integrated end-to-end solutions for development & commercialization of intermediates & APIs for small molecules.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 Listed Suppliers

1 API Suppliers
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 2035989-50-3, Olorigliflozin, Olorigliflozin [inn], 6fp3nst6zq, Chembl5314927, Schembl18195012

Molecular Formula

C₂₃H₂₇ClO₇

Molecular Weight

450.9 g/mol

InChI Key

KODGTDKHPNYCCJ-YWRILDCISA-N

FDA UNII

6FP3NST6ZQ

RONGLIFLOZIN is a small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication.

1 2D Structure

Rongliflozin

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(1R,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-[(1R)-1-hydroxyethyl]-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol

2.1.2 InChI

InChI=1S/C23H27ClO7/c1-3-29-17-7-4-14(5-8-17)10-15-11-16(6-9-18(15)24)23-21(28)19(26)20(27)22(31-23,12-30-23)13(2)25/h4-9,11,13,19-21,25-28H,3,10,12H2,1-2H3/t13-,19+,20+,21-,22-,23+/m1/s1

2.1.3 InChI Key

KODGTDKHPNYCCJ-YWRILDCISA-N

2.2 Other Identifiers

2.2.1 UNII

6FP3NST6ZQ

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Djt1116pg

2.3.2 Depositor-Supplied Synonyms

1. 2035989-50-3

2. Olorigliflozin

3. Olorigliflozin [inn]

4. 6fp3nst6zq

5. Chembl5314927

6. Schembl18195012

7. (1r,2s,3s,4r,5s)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-((r)-1-hydroxyethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol

8. 1,6-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-c-[(1r)-1-hydroxyethyl]-beta-l-idopyranose

9. Beta-l-idopyranose, 1,6-anhydro-1-c-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-c-[(1r)-1-hydroxyethyl]-

2.4 Create Date

2016-12-08

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₂₇ClO₇
Molecular Weight	450.9 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	6
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	109
Heavy Atom Count	31
Formal Charge	0
Complexity	615
Isotope Atom Count	0
Defined Atom Stereocenter Count	6
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1